The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
Open accessAbstract
Present review highlights various drug delivery systems used for delivery of pharmaceutical agents mainly antibiotics, antineoplastic agents, neuropeptides, and other therapeutic substances through the endothelial capillaries (BBB) for CNS therapeutics. In addition, the use of ultrasound in delivery of therapeutic agents/biomolecules such as proline rich peptides, prodrugs, radiopharmaceuticals, proteins, immunoglobulins, and chimeric peptides to the target sites in deep tissue locations inside tumor sites of brain has been explained. In addition, therapeutic applications of various types of nanoparticles such as chitosan based nanomers, dendrimers, carbon nanotubes, niosomes, beta cyclodextrin carriers, cholesterol mediated cationic solid lipid nanoparticles, colloidal drug carriers, liposomes, and micelles have been discussed with their recent advancements. Emphasis has been given on the need of physiological and therapeutic optimization of existing drug delivery methods and their carriers to deliver therapeutic amount of drug into the brain for treatment of various neurological diseases and disorders. Further, strong recommendations are being made to develop nanosized drug carriers/vehicles and noninvasive therapeutic alternatives of conventional methods for better therapeutics of CNS related diseases. Hence, there is an urgent need to design nontoxic biocompatible drugs and develop noninvasive delivery methods to check posttreatment clinical fatalities in neuropatients which occur due to existing highly toxic invasive drugs and treatment methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Atyabi, F., & Talaie, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s22731 · Cited by 42
RetractedBiodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.010 · Cited by 2,586
Structure and design of polymeric surfactant-based drug delivery systems
Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00299-1 · Cited by 1,822
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Green, N. M. (1975) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60411-8 · Cited by 1,458
Bae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200250653 · Cited by 1,329
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Advanced drug delivery devices via self-assembly of amphiphilic block copolymers
Rösler, A., Vandermeulen, G. W. M., & Klok, H.-A. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00222-8 · Cited by 1,168
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells
Vinogradov, S. V., Bronich, T. K., & Kabanov, A. V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00245-9 · Cited by 775
Hynynen, K., McDannold, N., Sheikov, N. A., Jolesz, F. A., & Vykhodtseva, N. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.046 · Cited by 679
Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering
Nitta, S., & Numata, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011629 · Cited by 666
Recent advances of chitosan nanoparticles as drug carriers
Zeng, Z. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17296 · Cited by 665
Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences
Anton, N., & Vandamme, T. F. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0309-1 · Cited by 621
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Supramolecular Drug‐Delivery Systems Based on Polymeric Core–Shell Architectures
Haag, R. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200301694 · Cited by 591
Molecular imprinting within hydrogels
Byrne, M. E., Park, K., & Peppas, N. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00246-0 · Cited by 569
Nanocapsule Technology: A Review
Couvreur, P., Barratt, G., Fattal, E., & Vauthier, C. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.10 · Cited by 555
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549
Delivery of Therapeutic Proteins
Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22054 · Cited by 532
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications
Vauthier, C., Dubernet, C., Fattal, E., Pinto-Alphandary, H., & Couvreur, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00041-3 · Cited by 527
Bioadhesive microspheres as a controlled drug delivery system
Vasir, J. K., Tambwekar, K., & Garg, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00087-5 · Cited by 524
Wiley, D. T., Webster, P., Gale, A., & Davis, M. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307152110 · Cited by 519
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 515
Delivery of peptides and proteins through the blood–brain barrier
Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00139-3 · Cited by 481
Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy
Yallapu, M. M., Othman, S. F., Curtis, E. T., Gupta, B. K., Jaggi, M., & Chauhan, S. C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.028 · Cited by 479
CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Pardridge, W. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051781.x · Cited by 460
Highly Water-Soluble, Porous, and Biocompatible Boron Nitrides for Anticancer Drug Delivery
Weng, Q., Wang, B., Wang, X., Hanagata, N., Li, X., Liu, D., Wang, X., Jiang, X., Bando, Y., & Golberg, D. (2014) · ACS Nano · doi:10.1021/nn5014808 · Cited by 455
Liposomal siRNA nanocarriers for cancer therapy
Ozpolat, B., Sood, A. K., & Lopez-Berestein, G. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.008 · Cited by 442
Is nose-to-brain transport of drugs in man a reality?
Illum, L. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022539 · Cited by 439
Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery
Desai, P., Patlolla, R. R., & Singh, M. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.522203 · Cited by 411
Müller-Goymann, C. C. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.028 · Cited by 404
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Molecularly imprinted polymers for drug delivery
Alvarez-Lorenzo, C., & Concheiro, A. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2003.12.032 · Cited by 387
Ansari, K. A., Vavia, P. R., Trotta, F., & Cavalli, R. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9584-3 · Cited by 381
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier
Miller, D. S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.03.003 · Cited by 361
Friedman, A. J., Phan, J., Schairer, D. O., Champer, J., Qin, M., Pirouz, A., Blecher-Paz, K., Oren, A., Liu, P. T., Modlin, R. L., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.399 · Cited by 345
Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma
Grapp, M., Wrede, A., Schweizer, M., Hüwel, S., Galla, H.-J., Snaidero, N., Simons, M., Bückers, J., Low, P. S., Urlaub, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3123 · Cited by 334
McDannold, N., Vykhodtseva, N., Raymond, S., Jolesz, F. A., & Hynynen, K. (2005) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2005.07.010 · Cited by 323
Hynynen, K., McDannold, N., Vykhodtseva, N., Raymond, S., Weissleder, R., Jolesz, F. A., & Sheikov, N. (2006) · Journal of Neurosurgery · doi:10.3171/jns.2006.105.3.445 · Cited by 314
The Shape of Things to Come: Importance of Design in Nanotechnology for Drug Delivery
Liu, Y., Tan, J., Thomas, A., Ou-Yang, D., & Muzykantov, V. R. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.156 · Cited by 299
Li, L., Hou, J., Liu, X., Guo, Y., Wu, Y., Zhang, L., & Yang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.019 · Cited by 289
Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model
Gao, J.-Q., Hu, Wang, & Han (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25853 · Cited by 285
Therapeutic applications of colloidal drug carriers
Barratt, G. M. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00255-8 · Cited by 282
Blood-Brain Barrier Carrier-Mediated Transport and Brain Metabolism of Amino Acids
Pardridge, W. M. (1998) · Neurochemical Research · doi:10.1023/a:1022482604276 · Cited by 281
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
Microchips as Controlled Drug-Delivery Devices
Santini, Jr., Richards, A. C., Scheidt, R., Cima, M. J., & Langer, R. (2000) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20000717)39:14<2396::aid-anie2396>3.0.co;2-u · Cited by 271
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
Gulino, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s23696 · Cited by 258
Intranasal Drug Delivery for Brain Targeting
Vyas, T., Shahiwala, A., Marathe, S., & Misra, A. (2005) · Current Drug Delivery · doi:10.2174/1567201053586047 · Cited by 257
Prodrugs: A challenge for the drug development
Zawilska, J. B., Wojcieszak, J., & Olejniczak, A. B. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)70959-9 · Cited by 251
Vandermeulen, G. W. M., & Klok, H. (2004) · Macromolecular Bioscience · doi:10.1002/mabi.200300079 · Cited by 248
Future directions of liposome- and immunoliposome-based cancer therapeutics
Park, J. W., Benz, C. C., & Martin, F. J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.009 · Cited by 240
The Role of Drug Transporters at the Blood-Brain Barrier
de Boer, A. G., van der Sandt, I. C. J., & Gaillard, P. J. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140204 · Cited by 238
Sink, K. M., Leng, X., Williamson, J., Kritchevsky, S. B., Yaffe, K., Kuller, L., Yasar, S., Atkinson, H., Robbins, M., Psaty, B., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.175 · Cited by 237
Nanobiotechnology-Based Strategies for Crossing The Blood–Brain Barrier
Jain, K. K. (2012) · Nanomedicine · doi:10.2217/nnm.12.86 · Cited by 233
Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkinson's disease?
Harrison, I. F., & Dexter, D. T. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.010 · Cited by 227
Fan, C.-H., Ting, C.-Y., Lin, H.-J., Wang, C.-H., Liu, H.-L., Yen, T.-C., & Yeh, C.-K. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.099 · Cited by 225 · cited 1×
“temporarily and locally opened by focused ultrasound in the presence of circulating microbubbles [124].”
BackgroundYokoyama, M. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903436479 · Cited by 224
Peroral Route: An Opportunity for Protein and Peptide Drug Delivery
Sood, A., & Panchagnula, R. (2001) · Chemical Reviews · doi:10.1021/cr000700m · Cited by 222
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219
Concepts and practices used to develop functional PLGA-based nanoparticulate systems
Sah, H., Desu, Sah, Wood, & Thoma (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40579 · Cited by 217
The role of the organ microenvironment in brain metastasis
Fidler, I. J. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.009 · Cited by 217
Op Den Kamp, J. A. F., & Roelofsen, B. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89065-9 · Cited by 213
Neuroprotection with noninvasive neurotrophin delivery to the brain
Wu, D., & Pardridge, W. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.254 · Cited by 205
A method to determine the ability of drugs to diffuse through the blood-brain barrier.
Seelig, A., Gottschlich, R., & Devant, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.68 · Cited by 197
Focused Ultrasound Delivers Targeted Immune Cells to Metastatic Brain Tumors
Alkins, R., Burgess, A., Ganguly, M., Francia, G., Kerbel, R., Wels, W. S., & Hynynen, K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2609 · Cited by 197
PHARMACOLOGY OF NEUROTROPHIC FACTORS
Hefti, F. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.239 · Cited by 186
Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy
Bellavance, M.-A., Blanchette, M., & Fortin, D. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9018-7 · Cited by 184
Albertazzi, L., Gherardini, L., Brondi, M., Sulis Sato, S., Bifone, A., Pizzorusso, T., Ratto, G. M., & Bardi, G. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300391v · Cited by 181
Yavlovich, A., Smith, B., Gupta, K., Blumenthal, R., & Puri, A. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.507788 · Cited by 178
Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System
Pérez-Martínez, F. C., Guerra, J., Posadas, I., & Ceña, V. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0364-7 · Cited by 177
Prodrug Approaches for CNS Delivery
Rautio, J., Laine, K., Gynther, M., & Savolainen, J. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9009-8 · Cited by 176
Chaudhury, A., & Das, S. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9561-2 · Cited by 174
Xenobiotic Metabolism and Berry Flavonoid Transport across the Blood−Brain Barrier
Milbury, P. E., & Kalt, W. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf903529m · Cited by 171
Functional lipids and lipoplexes for improved gene delivery
Zhang, X., McIntosh, T. J., & Grinstaff, M. W. (2011) · Biochimie · doi:10.1016/j.biochi.2011.05.005 · Cited by 167
Zhang, Y., & Pardridge, W. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03108-5 · Cited by 167
Atyabi, F., & Dinarvand, R. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26365 · Cited by 167
Frozza, R. L., Bernardi, A., Hoppe, J. B., Meneghetti, A. B., Matté, A., Battastini, A. M. O., Pohlmann, A. R., Guterres, S. S., & Salbego, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8401-2 · Cited by 165
Ultrasound and Microbubble Guided Drug Delivery: Mechanistic Understanding and Clinical Implications
Wang, T.-Y., Wilson, K., Machtaler, S., & Willmann, J. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201014666131226114611 · Cited by 162
Lipidic Systems for In Vivo siRNA Delivery
Wu, S. Y., & McMillan, N. A. J. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9140-1 · Cited by 160
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist
Ring, R. H., Schechter, L. E., Leonard, S. K., Dwyer, J. M., Platt, B. J., Graf, R., Grauer, S. M., Pulicicchio, C. M., Resnick, L., Rahman, Z. U., et al. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.016 · Cited by 156
Peptide and Protein Delivery Using New Drug Delivery Systems
Jain, A., Jain, A., Gulbake, A., Shilpi, S., Hurkat, P., & Jain, S. (2013) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2013006955 · Cited by 152
Pilakka‐Kanthikeel, S., Atluri, V. S. R., Sagar, V., Saxena, S. K., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062241 · Cited by 149
Etame, A. B., Diaz, R. J., Smith, C. A., Mainprize, T. G., Hynynen, K., & Rutka, J. T. (2011) · Neurosurgical FOCUS · doi:10.3171/2011.10.focus11252 · Cited by 149
Subarachnoid Space of the CNS, Nasal Mucosa, and Lymphatic System
Jackson, R. T., Tigges, J., & Arnold, W. J. (1979) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1979.00790160014003 · Cited by 143
Pardridge, W. M., Wu, D., & Sakane, T. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981927620 · Cited by 139
Ye, Q., Ye, L., Xu, X.-J., Huang, B., Zhang, X., Zhu, Y., & Chen, X. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-82 · Cited by 139
Dandawate, P. R., Vyas, A., Ahmad, A., Banerjee, S., Deshpande, J., Swamy, K. V., Jamadar, A., Dumhe-Klaire, A. C., Padhyé, S., & Sarkar, F. H. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0700-1 · Cited by 135
Regulation of Blood-Brain Tumor Barrier Permeability by Calcium-Activated Potassium Channels
Ningaraj, N. S., Rao, M. K., Hashizume, K., Asotra, K., & Black, K. L. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.838 · Cited by 130
Potential of Nanoparticulate Drug Delivery Systems by Intranasal Administration
Ali, J., Ali, M., Baboota, S., Sahni, J. K., Ramassamy, C., Dao, L. H., & Bhavna (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791164108 · Cited by 130
Zechariah, A., ElAli, A., Doeppner, T. R., Jin, F., Hasan, M. R., Helfrich, I., Mies, G., & Hermann, D. M. (2013) · Stroke · doi:10.1161/strokeaha.111.000240 · Cited by 129
Wang, X., Sykes, D. B., & Miller, D. S. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.063685 · Cited by 127
Sakane, T., & Pardridge, W. M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012117815460 · Cited by 126
Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults
Cornford, E. M., Braun, L. D., Oldendorf, W. H., & Hill, M. A. (1982) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1982.243.3.c161 · Cited by 125
Tumor targeting and microenvironment-responsive nanoparticles for gene delivery
Huang, S., Shao, K., Kuang, Y., Liu, Y., Li, J., An, S., Guo, Y., Ma, H., He, X., & Jiang, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.043 · Cited by 123
Ying, W. (2006) · Frontiers in bioscience · doi:10.2741/2267 · Cited by 123
Banerjee, A., Zhang, X., Manda, K. R., Banks, W. A., & Nuran Ercal, A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.023 · Cited by 122
Ding, H., Sagar, V., Agudelo, M., Pilakka-Kanthikeel, S., Atluri, V. S. R., Raymond, A., Samikkannu, T., & Nair, M. P. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/5/055101 · Cited by 119
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
Kanwar, J. R., Sriramoju, & Kanwar (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30919 · Cited by 119
Delivery of Bioactive Peptides and Proteins Across Oral (Buccal) Mucosa
Senel, S., Kremer, M. J., Katalin, N., & Squier, C. A. (2001) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201013378734 · Cited by 119
Modulation of Brain Tumor Capillaries for Enhanced Drug Delivery Selectively to Brain Tumor
Black, K. L., & Ningaraj, N. S. (2004) · Cancer Control · doi:10.1177/107327480401100304 · Cited by 115
Erythropoietin as a novel neuroprotectant.
Genç, Ş., Köroğlu, T., & Genç, K. (2004) · PubMed · Cited by 113
A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization
Jeyasekharan, A. D. D., Liu, Y., Hattori, H., Pisupati, V., Jonsdottir, A. B., Rajendra, E., Lee, M.-Y., Sundaramoorthy, E., Schlachter, S. C., Kaminski, C. F., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2666 · Cited by 113
Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells
Zhang, X., Shi, S., Jia, Zhao, 。., Guo, Chen, Guo, & Cheng, C. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34348 · Cited by 110
Gil, E. S., Li, J., Xiao, H., & Lowe, T. L. (2009) · Biomacromolecules · doi:10.1021/bm801026k · Cited by 110
Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery
Nguyen, D. N., Mahon, K. P., Chikh, G., Kim, P., Chung, H., Vicari, A. P., Love, K. T., Goldberg, M. S., Chen, S., Krieg, A. Μ., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121423109 · Cited by 110
Kadiyala, I., Loo, Y., Roy, K., Rice, J., & Leong, K. W. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.11.002 · Cited by 109
Jeon, M., Song, W., Huynh, E., Kim, J., Kim, J., Helfield, B. L., Leung, B. Y. C., Goertz, D. E., Zheng, G., Oh, J., et al. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.1.016005 · Cited by 106
Prakash, S., Malhotra, M., Lane, C., Tomaro-Duchesneau, C., Saha, S., Prakash, S., & Malhotra, M. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17190 · Cited by 106
Paterson, B. M., Roselt, P. D., Denoyer, D., Cullinane, C. M., Binns, D., Noonan, W., Jeffery, C. M., Price, R. I., White, J. M., Hicks, R. J., et al. (2013) · Dalton Transactions · doi:10.1039/c3dt52647j · Cited by 105
Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier
Wohlfart, S., Khalansky, A. S., Gelperina, S. E., Begley, D. J., & Kreuter, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.010 · Cited by 102
Howard, M. D., Greineder, C. F., Hood, E. D., & Muzykantov, V. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.035 · Cited by 102
2,5-Diketopiperazines as Neuroprotective Agents
Cornacchia, C., Cacciatore, I., Baldassarre, L., Mollica, A., Feliciani, F., & Pinnen, F. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712798868959 · Cited by 102
Blakeley, J. O. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0036-8 · Cited by 101
Drug delivery through the blood-brain barrier
Tamai, I., & Tsuji, A. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00011-7 · Cited by 101
Derakhshan, F. N., & Toth, C. C. (2013) · Current Diabetes Reviews · doi:10.2174/1573399811309020002 · Cited by 98
GDNF fusion protein for targeted‐drug delivery across the human blood–brain barrier
Boado, R. J., Zhang, Y., Zhang, Y., Wang, Y., & Pardridge, W. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21764 · Cited by 98
Songjiang, Z., & Wu, L. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9279-1 · Cited by 96
Ng, K., Mabasa, V. H., Chow, I., & Ensom, M. H. H. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9784-z · Cited by 96
Chen, C., Lu, D., Yeh, Y., Shiau, & Chiang (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24447 · Cited by 95
Virus-derived siRNAs and piRNAs in immunity and pathogenesis
Ding, S., & Lu, R. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.028 · Cited by 94
Gene transfer to hemophilia A mice via oral delivery of FVIII–chitosan nanoparticles
Bowman, K., Sarkar, R., Raut, S., & Leong, K. W. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.06.019 · Cited by 94
Wang, X., Vaccari, J. P. D. R., Wang, H., Diaz, P., German, R., Marcillo, A. E., & Keane, R. W. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1922 · Cited by 94
In vitro and in vivo platelet targeting by cyclic RGD‐modified liposomes
Srinivasan, R., Marchant, R. E., & Gupta, A. S. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32549 · Cited by 91
Toborek, M. J., Seelbach, M. J., Rashid, C. S., Andras, I. E., Chen, L., Park, M., & Esser, K. A. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-22 · Cited by 91
Jain, A. S., Date, A. A., Pissurlenkar, R. R. S., Coutinho, E. C., & Nagarsenker, M. S. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9685-z · Cited by 91
Zhang, J., Ellsworth, K., & Ma, P. X. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.019 · Cited by 90
Wang, J., Liu, K., Sung, K. C., Tsai, C.-Y., & Fang, J. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.008 · Cited by 88
Nanofiber-Based Delivery of Therapeutic Peptides to the Brain
Mazza, M., Notman, R., Anwar, J., Rodger, A., Hicks, M. R., Parkinson, G. N., McCarthy, D. C., Daviter, T., Moger, J., Garrett, N., et al. (2013) · ACS Nano · doi:10.1021/nn305193d · Cited by 88
Michaelides, M., Anderson, S. A. R., Ananth, M. R., Smirnov, D. S., Thanos, P. K., Neumaier, J. F., Wang, G., Volkow, N. D., & Hurd, Y. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci72117 · Cited by 88
Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke
Mdzinarishvili, A., Sutariya, V. B., Talasila, P. K., Geldenhuys, W. J., & Sadana, P. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0117-8 · Cited by 88
Prodrugs - An Efficient Way to Breach Delivery and Targeting Barriers
Huttunen, K. M., & Rautio, J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611797183230 · Cited by 86
Pulford, B., Reim, N., Bell, A., Veatch, J., Forster, G., Bender, H., Meyerett, C., Hafeman, S., Michel, B., Johnson, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011085 · Cited by 85
LeBras, M. H., Chow, I., Mabasa, V. H., & Ensom, M. H. H. (2016) · Neurocritical Care · doi:10.1007/s12028-016-0269-3 · Cited by 85
Roger, M., Clavreul, A., Venier‐Julienne, M., Passirani, C., Montero‐Menei, C. N., & Meneï, P. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.056 · Cited by 83
Merzouki, A., Alameh, M., DeJesus, D., Jean, M., Darras, V., Thibault, M., Lavertu, M., & Buschmann, M. D. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26571 · Cited by 82
P-Glycoprotein Attenuates Brain Uptake of Substrates After Nasal Instillation
Graff, C. L., & Pollack, G. M. (2003) · Pharmaceutical Research · doi:10.1023/a:1025053115583 · Cited by 81
Regulation of ABC Transporters at the Blood-Brain Barrier: New Targets for CNS Therapy
Hartz, A. M. S., & Bauer, B. (2010) · Molecular Interventions · doi:10.1124/mi.10.5.6 · Cited by 79
Properties, characteristics and applications of microbubbles for sonothrombolysis
Victor, M. D. S., Crake, C., Coussios, C. C., & Stride, E. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.868434 · Cited by 79
López‐Noriega, A., Hastings, C. L., Ozbakir, B., O’Donnell, K., O’Brien, F. J., Storm, G., Hennink, W. E., Duffy, G. P., & Ruiz‐Hernández, E. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300649 · Cited by 78
Kim, M.-S., Lee, D., Park, K., Park, S., Choi, E.-J., Park, E. S., & Kim, H. R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.12.045 · Cited by 73
Engineered Nanoparticulate Drug Delivery Systems: The Next Frontier for Oral Administration?
Diab, R., Jaafar‐Maalej, C., Fessi, H., & Maincent, P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9377-y · Cited by 73
Jain, S., Yap, W. T., & Irvine, D. J. (2005) · Biomacromolecules · doi:10.1021/bm0503221 · Cited by 72
Dadparvar, M., Wagner, S., Wien, S., Kufleitner, J., Worek, F., von Briesen, H., & Kreuter, J. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.06.027 · Cited by 72
Kurihara, A., Deguchi, Y., & Pardridge, W. M. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980123x · Cited by 70
Yan, F., Wang, Y., He, S., Ku, S., Gu, W., & Ye, L. (2013) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-013-4993-3 · Cited by 69
Molecular Properties of Lysine Dendrimers and their Interactions with Aβ-Peptides and Neuronal Cells
Neelov, I. M., Janaszewska, A., Klajnert‐Maculewicz, B., Bryszewska, M. J., Makova, N. Z., Hicks, D. A., Pearson, H. A., Vlasov, G. P., Ilyash, M., Vasilev, D. S., et al. (2012) · Current Medicinal Chemistry · doi:10.2174/0929867311302010013 · Cited by 69
The inverse electron demand Diels–Alder click reaction in radiochemistry
Reiner, T., & Zeglis, B. M. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3149 · Cited by 69
Neurotrophins, neuroprotection and the blood-brain barrier.
Pardridge, W. M. (2002) · PubMed · Cited by 69
Ninomiya, K., Yamashita, T., Kawabata, S., & Shimizu, N. (2014) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2013.12.023 · Cited by 67
Kowalski, P. S., Zwiers, P. J., Morselt, H. W. M., Kuldo, J., Leus, N. G. J., Ruiters, M. H. J., Molema, G., & Kamps, J. A. A. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.029 · Cited by 67
Li, Y., Su, T., Zhang, Y., Huang, X., Li, J., & Li, C. (2014) · Drug Delivery · doi:10.3109/10717544.2014.880756 · Cited by 67
García-Rodríguez, J. C., & Testé, I. S. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.103 · Cited by 66
Ningaraj, N. S., Rao, M. K., & Black, K. L. (2003) · PubMed · Cited by 64
Current Prodrug Design for Drug Discovery
Hsieh, P., Hung, C., & Fang, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682523 · Cited by 64
Liposome surface functionalization based on different anchoring lipids via Staudinger ligation
Vabbilisetty, P., & Sun, X. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41721b · Cited by 63
Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties
Gradauer, K., Dünnhaupt, S., Vonach, C., Szöllösi, H., Pali-Schöll, I., Mangge, H., Jensen‐Jarolim, E., Bernkop‐Schnürch, A., & Prassl, R. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.001 · Cited by 63
Metallothioneins I and II: Neuroprotective significance during CNS pathology
Stankovic, R. K., Chung, R. S., & Penkowa, M. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.09.010 · Cited by 63
Disposition of Ultrasound Sensitive Polymeric Drug Carrier in a Rat Hepatocellular Carcinoma Model
Cochran, M. C., Eisenbrey, J. R., Soulen, M. C., Schultz, S. M., Ouma, R. O., White, S. B., Furth, E. E., & Wheatley, M. A. (2011) · Academic Radiology · doi:10.1016/j.acra.2011.06.013 · Cited by 62
Fargo, K. N., Alexander, T. D., Tanzer, L., Poletti, A., & Jones, K. J. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0466 · Cited by 62
Anthraquinone-2-sulfonic acid (AQ2S) is A Novel Neurotherapeutic Agent
Jackson, T. C., Verrier, J. D., & Kochanek, P. M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.187 · Cited by 62
Controlling membrane permeability with bacterial porins: application to encapsulated enzymes
Winterhalter, M. (2001) · Talanta · doi:10.1016/s0039-9140(01)00494-5 · Cited by 61
Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier.
Kurihara, A., & Pardridge, W. M. (1999) · PubMed · Cited by 61
Melittin-grafted HPMA-oligolysine based copolymers for gene delivery
Schellinger, J. G., Pahang, J. A., Johnson, R. N., Chu, D. S. H., Sellers, D. L., Maris, D. O., Convertine, A. J., Stayton, P. S., Horner, P. J., & Pun, S. H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.072 · Cited by 60
Biswas, S., Dodwadkar, N. S., Sawant, R. R., & Torchilin, V. P. (2011) · Bioconjugate Chemistry · doi:10.1021/bc2002133 · Cited by 60
Tan, Z. T., Turner, R. C., León, R. L., Li, X., Hongpaisan, J., Zheng, W., Logsdon, A. F., Naser, Z. J., Alkon, D. L., Rosen, C. L., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.002411 · Cited by 59
Özcan, İ., Azizoğlu, E., Şenyiğit, T., Ozyazici, & Özer, Ö. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s40519 · Cited by 58
Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam
Scarpignato, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990115 · Cited by 57
El‐Badry, M., Fetih, G. N., & Shakeel, F. (2013) · Drug Delivery · doi:10.3109/10717544.2013.843610 · Cited by 57
Tagalakis, A. D., Kenny, G. D., Bienemann, A. S., McCarthy, D., Munye, M. M., Taylor, H., Wyatt, M. J., Lythgoe, M. F., White, E. A., & Hart, S. L. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.014 · Cited by 56
Mahjub, R., Dorkoosh, F. A., Amini, M., Khoshayand, M. R., & Rafiee‐Tehrani, M. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9716-9 · Cited by 55
Chung, C., Chung, Jeong, Y., & Kang, D. H. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s39615 · Cited by 55
Liu, H.-L., Yang, H., Hua, M., & Wei, K. (2011) · Neurosurgical FOCUS · doi:10.3171/2011.10.focus11238 · Cited by 52
Kurihara, A., & Pardridge, W. M. (2000) · Bioconjugate Chemistry · doi:10.1021/bc9901393 · Cited by 52
Drug Delivery Systems for Brain Tumor Therapy
Rautioa, J., & Chikhale, P. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384916 · Cited by 51
Lila, A. S. A., Uehara, Y., Ishida, T., & Kiwada, H. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23823 · Cited by 51
Gonçalves, C., Berchel, M., Gosselin, M.-P., Malard, V., Cheradame, H., Jaffrès, P., Guégan, P., Pichon, C., & Midoux, P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.005 · Cited by 51
Fross, R. D., Warnke, P. C., & Groothuis, D. R. (1991) · Journal of Neuro-Oncology · doi:10.1007/bf00165526 · Cited by 48
Malatesta, M., Giagnacovo, M., Costanzo, M., Conti, B., Genta, I., Dorati, R., Galimberti, V., Biggiogera, M., & Zancanaro, C. (2012) · European Journal of Histochemistry · doi:10.4081/ejh.2012.20 · Cited by 48
Byerly, M. S., Swanson, R. D., Semsarzadeh, N. N., McCulloh, P. S., Kwon, K., Aja, S. M., Moran, T. H., Wong, G. W., & Blackshaw, S. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00368.2012 · Cited by 46
Kadoch, C., Li, J., Wong, V. S., Chen, L., Cha, S., Münster, P. N., Lowell, C. A., Shuman, M. A., & Rubenstein, J. L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0474 · Cited by 46
Weyerbrock, A., Walbridge, S., Pluta, R. M., Saavedra, J. E., Keefer, L. K., & Oldfield, E. H. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.4.0728 · Cited by 45
Sarker, S. R., Hokama, R., & Takeoka, S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400363z · Cited by 45
Reactive Oxygen Species Responsive Nanoprodrug to Treat Intracranial Glioblastoma
Lee, B., Amano, T., Wang, H., Pantoja, J. L., Yoon, C. W., Hanson, C. J., Amatya, R., Yen, A., Black, K. L., & Yu, J. S. (2013) · ACS Nano · doi:10.1021/nn400347j · Cited by 43
New systems for delivery of drugs to the brain in neurological disease
Cornford, E. M., & Cornford, M. E. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00136-9 · Cited by 43
Targeted Drug Delivery to the Brain Using Focused Ultrasound
Kinoshita, M. (2006) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e3180332e79 · Cited by 42
Sudhakar, B., Varma, J., & Murthy, K. V. (2014) · Current Drug Delivery · doi:10.2174/1567201810666140109113830 · Cited by 42
Intelligent Design of Multifunctional lipid-coated Nanoparticle Platforms for Cancer Therapy
Ramishetti, S., & Huang, L. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.127 · Cited by 42
Wei, X.-H., Zhang, Z., Zhao, & Liu (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s39685 · Cited by 42
Zhou, Q.-H., Hui, E. K., Lu, J. Z., Boado, R. J., & Pardridge, W. M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.061 · Cited by 41
Pathways of Infusate Loss during Convection-Enhanced Delivery into the Putamen Nucleus
Brady, M., Raghavan, R., Alexander, A. L., Kubota, K., Sillay, K. A., & Emborg, M. E. (2013) · Stereotactic and Functional Neurosurgery · doi:10.1159/000342492 · Cited by 41
Blood-Brain Barrier Transport of Short Proline-Rich Antimicrobial Peptides
Stalmans, S., Wynendaele, E., Bracke, N., Knappe, D., Hoffmann, R., Peremans, K. Y., Polis, I., Burvenich, C., & Spiegeleer, B. M. J. D. (2014) · Protein and Peptide Letters · doi:10.2174/09298665113206660110 · Cited by 40
Novak, A., Binnington, B., Ngan, B., Chadwick, K. R., Fleshner, N. E., & Lingwood, C. A. (2013) · Glycobiology · doi:10.1093/glycob/cwt059 · Cited by 40
Danjo, S., Ishihara, Y., Watanabe, M., Nakamura, Y., & Itoh, K. (2013) · Brain Research · doi:10.1016/j.brainres.2013.06.043 · Cited by 39
The Role of l-arginine in Inclusion Complexes of Omeprazole with Cyclodextrins
Figueiras, A., Sarraguça, J. M. G., Pais, A. A. C. C., Carvalho, R. A., & Veiga, F. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-009-9375-2 · Cited by 38
Cited by
Crossing the blood-brain barrier with nanoparticles
Zhou, Y., Peng, Z., Seven, E. S., & Leblanc, R. M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.015 · Cited by 837
Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Ronaldson-Bouchard, K., & Vunjak-Novakovic, G. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.011 · Cited by 657
Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro
Chen, C. C., Liu, L., Ma, F., Wong, C. W., Guo, X. E., Chacko, J. V., Farhoodi, H. P., Zhang, S. X., Zimak, J., Ségaliny, A., et al. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0458-3 · Cited by 537
A Review on Central Nervous System Effects of Gastrodin
Liu, Y., Gao, J., Peng, M., Meng, H., Ma, H., Cai, P., Xu, Y., Zhao, Q., & Si, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00024 · Cited by 387
Autophagy as a molecular target for cancer treatment
Kocaturk, N. M., Akkoc, Y., Kig, C., Bayraktar, O., Gozuacik, D., & Kutlu, O. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.011 · Cited by 387
Metadata
- Authors
- Upadhyay, R. K.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-37
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2164322384
- Cited by
- 528
- References
- 239
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.